Your browser doesn't support javascript.
loading
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Beigel, John H; Bao, Yajing; Beeler, Joy; Manosuthi, Weerawat; Slandzicki, Alex; Dar, Sadia M; Panuto, John; Beasley, Richard L; Perez-Patrigeon, Santiago; Suwanpimolkul, Gompol; Losso, Marcelo H; McClure, Natalie; Bozzolo, Dawn R; Myers, Christopher; Holley, H Preston; Hoopes, Justin; Lane, H Clifford; Hughes, Michael D; Davey, Richard T.
Afiliação
  • Beigel JH; Leidos Biomedical Research, Frederick, MD, USA. Electronic address: jbeigel@niaid.nih.gov.
  • Bao Y; Harvard T H Chan School of Public Health, Boston, MA, USA.
  • Beeler J; Leidos Biomedical Research, Frederick, MD, USA.
  • Manosuthi W; Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand.
  • Slandzicki A; Clinical Research Solutions, Franklin, TN, USA.
  • Dar SM; Clinical Research Solutions, Smyrna, TN, USA.
  • Panuto J; Clinical Research Solutions, Middleburg Heights, OH, USA.
  • Beasley RL; Health Concepts, Rapid City, SD, USA.
  • Perez-Patrigeon S; Instituto Nacional De Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Suwanpimolkul G; King Chulalongkorn Memorial Hospital, Department of Medicine, Chulalongkorn University, Bangkok, Thailand; HIV-NAT, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
  • Losso MH; Hospital General De Agudos J M Ramos Mejía, Buenos Aires, Argentina.
  • McClure N; Adamas Pharmaceuticals, Emeryville, CA, USA.
  • Bozzolo DR; Social & Scientific Systems Inc, Silver Spring, MD, USA.
  • Myers C; Naval Health Research Center, San Diego, CA, USA.
  • Holley HP; Leidos Biomedical Research, Frederick, MD, USA.
  • Hoopes J; AVR Laboratories LLC, Logan, UT, USA.
  • Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Hughes MD; Harvard T H Chan School of Public Health, Boston, MA, USA.
  • Davey RT; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Lancet Infect Dis ; 17(12): 1255-1265, 2017 12.
Article em En | MEDLINE | ID: mdl-28958678

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribavirina / Amantadina / Influenza Humana / Oseltamivir Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: America do sul / Argentina / Asia / Mexico / Oceania Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribavirina / Amantadina / Influenza Humana / Oseltamivir Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: America do sul / Argentina / Asia / Mexico / Oceania Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos